Harbour Investments’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Harbour Investments’s Portfolio OMIC Stock Details OMIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5	Closed	-$97	–	3694
2024 Q4	$97	Hold	5	–	–	﹤0.01%	3405
2024 Q3	$78	Hold	5	–	–	﹤0.01%	3328
2024 Q2	$42	Sell	5 -1	-17%	-$12	﹤0.01%	3247
2024 Q1	$88	Hold	6	–	–	﹤0.01%	3154
2023 Q4	$79	Hold	6	–	–	﹤0.01%	3065
2023 Q3	$66	Hold	6	–	–	﹤0.01%	2944
2023 Q2	$143	Hold	6	–	–	﹤0.01%	2922
2023 Q1	$208	Buy	+6	New	+$368	﹤0.01%	2874
2021 Q4	–	Sell	-6	Closed	-$2K	–	3824
2021 Q3	$2K	Hold	6	–	–	﹤0.01%	3393
2021 Q2	$5K	Buy	+6	New	+$4.65K	﹤0.01%	3103

Harbour Investments's OMIC Position: Q1 2025 in Review

Harbour Investments sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q1 2025, closing a stake of 5 shares — an estimated $97 sold.

Harbour Investments first reported a position in OMIC in Q2 2021 and held it in 10 quarters. The position peaked at $5K in Q2 2021. 0 funds tracked by Wall St. Rank hold OMIC as of Q1 2025.

Harbour Investments reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Harbour Investments sold 5 Singular Genomics Systems, Inc. Common Stock shares in Q1 2025, an estimated $97.
Harbour Investments first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2021 and held it in 10 quarters.
Harbour Investments's Singular Genomics Systems, Inc. Common Stock position peaked at $5K in Q2 2021.
0 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q1 2025.

Based on Harbour Investments's 13F filing for Q1 2025, filed 8 May 2025.